• 669 Citations
  • 13 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

Currently I am involved with Lipoprotein drug delivery research as it pertains to my training and experience with development of novel nanotechnology applications for theranostic purposes. The objective of my research is to develop lipoprotein based therapies and diagnostics. rHDL based therapy will significantly lower the off-target toxicities and will prolong the blood circulation time (Mean Residence Time) thereby increasing the selective delivery of the dose to cancer cells via SR-B1 receptor. These receptors are exclusively overexpressed on many cancer cells and extract the drug from rHDL nanoparticles without endocytosing them.
The projects in my lab will exploit recently developed technology of lipoprotein nanoparticles and will exploit unique interaction of rHDL and SR-B1 receptors for treatment of various cancers ( breast, prostate, ovarian, Ewing sarcoma, neuroblastoma, etc.). This new technology will be tested for in-vitro toxicity in various cell lines and ex-vivo 3D tissue models, and then studies will be carried out in small animal models, followed by patient-derived xenograft animal studies in collaboration with other institutions or commercial outfits.

Education/Academic qualification

PhD in Biomedical Sciences, UNT Health Science Center

MS in Industrial Pharmacy, St. John's University

BS in Pharmaceutical Science, Shivaji University

Fingerprint Dive into the research topics where Sangram Raut is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Fluorescence Chemical Compounds
fluorescence Physics & Astronomy
Fluorophores Chemical Compounds
Coloring Agents Chemical Compounds
Silver Chemical Compounds
Nanoparticles Chemical Compounds
Nanoclusters Chemical Compounds
Dyes Engineering & Materials Science

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2022

Research Output 2010 2019

[ 99 mTc-HYNIC-N-dodecylamide]:a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging

Isaac-Olivé, K., Ocampo-García, B. E., Aranda-Lara, L., Santos-Cuevas, C. L., Jiménez-Mancilla, N. P., Luna-Gutiérrez, M. A., Medina, L. A., Nagarajan, B., Sabnis, N., Raut, S. L., Prokai, L. & Lacko, A. G., 14 Jan 2019, In : Nanoscale. 11, 2, p. 541-551 11 p.

Research output: Contribution to journalArticleResearchpeer-review

HDL Lipoproteins
Imaging techniques
1 Citation (Scopus)

Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells

Shelake, S., Sankpal, U. T., Eslin, D., Bowman, P., Simecka, J., Raut, S. L., Ray, A. & Basha, R. M., 15 Feb 2019, In : Apoptosis. 24, 1-2, p. 21-32 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Ewing's Sarcoma
Caspase 7
Cell Survival

Identifying and targeting angiogenesis-related microRNAs in ovarian cancer

Chen, X., Mangala, L. S., Mooberry, L., Bayraktar, E., Dasari, S. K., Ma, S., Ivan, C., Court, K. A., Rodriguez-Aguayo, C., Bayraktar, R., Raut, S. L., Sabnis, N., Kong, X., Yang, X., Lopez-Berestein, G., Lacko, A. G. & Sood, A. K., 15 Aug 2019, In : Oncogene. 38, 33, p. 6095-6108 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Ovarian Neoplasms
CD36 Antigens
Vascular Endothelial Growth Factor A

The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

Berney, E., Sabnis, N., Panchoo, M., Raut, S. L., Dickerman, R. & Lacko, A. G., 1 Jan 2019, In : Journal of Oncology. 2019, 1805841.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Scavenger Receptors
HDL Lipoproteins
Cell Cycle

Brain targeting of payload using mild magnetic field: Site specific delivery

Bommana, M. M. & Raut, S. L., 16 Feb 2018, Nanostructures for the Engineering of Cells, Tissues and Organs: From Design to Applications. Elsevier, p. 167-185 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

Magnetic Fields
Magnetic fields